Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012... Show more
Mondelez International stands as a snacking powerhouse, commanding top global market shares in core categories that drive resilient consumer demand. As the world's leading biscuits producer with approximately 17% share—bolstered by powerhouse brands like Oreo—and second in chocolate at around 13% with Cadbury and Milka, the company benefits from scale advantages in procurement, distribution, and marketing. Its portfolio focuses on high-growth snacking segments, where these categories expand 1.4 times faster than broader food markets, positioning Mondelez for structural outperformance.
Strategic priorities center on three pillars: Growth, Execution, and Culture, underpinned by sustainability. Growth emphasizes expanding in emerging markets (40% of revenue) and innovating for health-conscious consumers via premium and functional snacks. Execution leverages AI for supply chain efficiency and localized strategies, while Culture fosters innovation through diverse teams. Medium-term, disciplined M&A (mergers and acquisitions) and cost management aim to sustain 3-5% long-term ONR growth, enhancing competitive moats amid industry consolidation.
The Q1 2026 earnings release on April 28 represents a pivotal near-term event, where management may update on volume trends, cocoa mitigation, and FY2026 trajectory following a cautious initial outlook. Investors will scrutinize progress toward margin recovery as cocoa costs ease, potentially boosting sentiment if volumes stabilize.
Analyst activity remains dynamic, with recent actions including BTIG's Buy initiation at $70 (April 14) and Bank of America's target hike to $65 (April 10), alongside cautious adjustments like Deutsche Bank's cut to $54 (March 30). Overall, the Moderate Buy consensus reflects optimism on structural strengths despite mixed revisions.
Other catalysts include product innovations in health-oriented snacks, potential bolt-on acquisitions, and regional expansions. Cocoa supply improvements in West Africa could accelerate margin tailwinds, influencing price target trends positively if realized ahead of expectations.
Mondelez's trajectory hinges on snacking industry evolution toward premium, convenient, and healthier options, aligning with its portfolio. However, consumer staples face headwinds from inflation-weary demand, prompting value-seeking behaviors in developed markets like the US and Europe (60% of revenue).
Commodity sensitivities loom large, particularly cocoa prices, which inflated chocolate pricing in 2025 but are normalizing in 2026 via better West African weather and supply dynamics— a boon for margins. Broader macro factors like interest rates and geopolitical tensions could pressure emerging market growth, though snacking's defensive nature provides resilience. Regulatory pushes for sustainable sourcing further favor Mondelez's proactive sustainability pillar.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it includes searchable prediction categories, historical context, and alert-oriented functionality. This enables users to stay ahead of momentum shifts with data-driven insights. Explore the Trend Prediction Engine today for enhanced trading decisions.
For 2026, Mondelez guides flat to 2% ONR growth and flat to 5% adjusted EPS expansion, tempering expectations amid softer volumes but banking on cocoa normalization and supply chain efficiencies for margin gains. Emerging markets expansion remains a core driver, leveraging snacking's superior growth profile, while developed market strategies target value and premium segments.
Longer-term themes include technology adoption like AI for consumer insights, portfolio evolution toward wellness snacks (e.g., Clif Bar integration), and capital allocation via dividends and buybacks. Competitive threats from private labels and sustainability regulations warrant monitoring, but consensus analyst expectations—centered on a $66+ price target—signal confidence in 3-5% structural ONR trajectory. Watch for execution on cost discipline and innovation to shape investor sentiment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a manufacturer of packaged food products
Industry FoodSpecialtyCandy
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SHYM | 22.20 | 0.02 | +0.07% |
| iShares Short Duration HY Muni Act ETF | |||
| UJB | 78.35 | -0.08 | -0.10% |
| ProShares Ultra High Yield | |||
| SCHR | 24.74 | -0.06 | -0.24% |
| Schwab Intermediate-Term US Trs ETF™ | |||
| PXJ | 43.62 | -0.76 | -1.72% |
| Invesco Oil & Gas Services ETF | |||
| FAX | 14.50 | -0.30 | -2.03% |
| abrdn Asia-Pacific Income Fund | |||
A.I.dvisor indicates that over the last year, MDLZ has been loosely correlated with GIS. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if MDLZ jumps, then GIS could also see price increases.
| Ticker / NAME | Correlation To MDLZ | 1D Price Change % | ||
|---|---|---|---|---|
| MDLZ | 100% | -0.91% | ||
| GIS - MDLZ | 65% Loosely correlated | +1.82% | ||
| CAG - MDLZ | 59% Loosely correlated | +2.06% | ||
| CPB - MDLZ | 58% Loosely correlated | +1.43% | ||
| KHC - MDLZ | 58% Loosely correlated | +2.47% | ||
| MKC - MDLZ | 58% Loosely correlated | -1.22% | ||
More | ||||
The 10-day moving average for MDLZ crossed bullishly above the 50-day moving average on April 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 28, 2026. You may want to consider a long position or call options on MDLZ as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MDLZ just turned positive on April 28, 2026. Looking at past instances where MDLZ's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
MDLZ moved above its 50-day moving average on April 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDLZ advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 225 cases where MDLZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MDLZ moved out of overbought territory on May 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDLZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MDLZ broke above its upper Bollinger Band on April 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.056) is normal, around the industry mean (2.968). P/E Ratio (30.351) is within average values for comparable stocks, (22.943). Projected Growth (PEG Ratio) (1.007) is also within normal values, averaging (0.823). Dividend Yield (0.032) settles around the average of (0.029) among similar stocks. P/S Ratio (2.017) is also within normal values, averaging (1.824).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDLZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDLZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.